West Nile Virus workshop: scientific considerations for tissue donors
- PDF / 228,234 Bytes
- 13 Pages / 547.087 x 737.008 pts Page_size
- 6 Downloads / 186 Views
West Nile Virus workshop: scientific considerations for tissue donors Scott A. Brubaker • P. Robert Rigney
Received: 16 November 2011 / Accepted: 18 November 2011 / Published online: 2 December 2011 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract This report contains selected excerpts, presented as a summary, from a public workshop sponsored by the American Association of Tissue Banks (AATB) held to discuss West Nile Virus (WNV) and scientific considerations for tissue donors. The daylong workshop was held 9 July 2010 at the Ritz-Carlton Hotel at Tyson’s Corner in McLean, Virginia, United States (U.S.). The workshop was designed to determine and discuss scientific information that is known, and what is not known, regarding WNV infection and transmission. The goal is to determine how to fill gaps in knowledge of WNV and tissue donation and transplantation by pursuing relevant scientific studies. This information should ultimately support decisions leading to appropriate tissue donor screening and testing considerations. Discussion topics were related to identifying these gaps and determining possible solutions. Workshop participants included subject-matter experts from the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Health Canada, the Public Health Agency of Canada, AATB-accredited tissue banks including reproductive tissue banks, accredited eye banks of the Eye Bank Association of America, testing laboratories, and infectious disease and organ S. A. Brubaker (&) P. Robert Rigney American Association of Tissue Banks (AATB), 1320 Old Chain Bridge Road, Suite 450, McLean, VA 22101, USA e-mail: [email protected]
transplantation professionals. After all presentations concluded, a panel addressed this question: ‘‘What are the scientific considerations for tissue donors and what research could be performed to address those considerations?’’ The slide presentations from the workshop are available at: http://www.aatb.org/2010-West-NileVirus-Workshop-Presentations. Keywords West Nile Virus Tissue donor Allograft Research Risk Transmission
Opening remarks P. Robert Rigney, Jr., Esq. Chief Executive Officer, AATB Bob Rigney opened the workshop by welcoming attendees to this ‘‘critically important meeting.’’ He briefly reviewed the history of the Food and Drug Administration’s (FDA’s) proposed rulemaking on West Nile Virus (WNV) testing and the AATB’s response that produced this workshop. He also thanked the various offices within FDA and the Centers for Disease Control and Prevention (CDC) for their assistance in developing the workshop. Mr. Rigney highlighted that the principal goal for the workshop was ‘‘to evaluate what is known about WNV, and what studies might need to be done to assess the value of WNV testing of tissue donors. We believe an outcome of this workshop will be to pursue
123
500
scientific studies that adequately characterize WNV, and that will support any final
Data Loading...
